Unliganded estrogen receptor alpha regulates vascular cell function and gene expression

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Molecular Biology

Background:

• The estrogen receptor alpha (ERα) is typically considered inactive without a ligand.
• Previous research indicated unliganded ERα may worsen vascular injury.
• The precise role of unliganded ERα in vascular cell physiology and gene regulation remained unclear.

Purpose of the Study:

• To investigate the physiological and gene regulatory roles of unliganded estrogen receptor alpha (ERα) in vascular cells.
• To determine if estrogen (E2) activation of ERα can reverse the effects of the unliganded form.
• To explore the implications for cardiovascular health and estrogen's protective mechanisms.

Main Methods:

• In vitro studies using cultured endothelial cells (ECs) and smooth muscle cells (SMCs).
• Assessment of cell migration, proliferation, and inflammatory responses.
• Gene expression analysis in vascular cells and mouse aorta.
• Comparison of effects with and without E2 activation of ERα.

Main Results:

• Unliganded ERα significantly reduced EC migration and proliferation.
• Unliganded ERα increased SMC proliferation and inflammatory responses in ECs and SMCs.
• Unliganded ERα modulated numerous genes in vascular ECs and mouse aorta.
• E2 activation of ERα reversed the detrimental cellular effects and altered gene expression profiles.

Conclusions:

• The unliganded form of ERα is biologically active and detrimentally affects vascular cell function and gene expression.
• Estrogen's cardiovascular benefits may stem from ERα activation counteracting the adverse actions of unliganded ERα.
• These findings challenge the traditional view of ERα inactivity in the absence of ligands and highlight a novel aspect of estrogen signaling in vascular health.